Raboral V-RG (vaccine against rabies) [DRAFT] | BCH-LMO-SCBD-100345 | Living Modified Organism | Biosafety Clearing-House

Loading...
Living Modified Organism (LMO)
  |  
Decisions on the LMO Risk Assessments  
published: 10 Aug 2009 last updated: 14 Sep 2018
Living Modified Organism identity
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.
Raboral V-RG (vaccine against rabies) [DRAFT]
EN
Not available [DRAFT]
No
  • - Organization: Rhône Mérieux () | BCH-CON-SCBD-49388-1
    Organization:
    Rhône Mérieux ()
    Phone:
    Fax:
    Email:
    Website:
The glygoprotein G from the rabies virus was cloned and expressed into the vaccinia virus strain Copenhagen (tk- phenotype) to produce a vaccine called RABORAL V-RG®.
EN
The term “Recipient organism” refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas “Parental organisms” refers to those that were involved in cross breeding or cell fusion.
Vaccinia virus Copenhagen (tk- phenotype)strain used
EN
Characteristics of the modification process
EN
Some of these genetic elements may be present as fragments or truncated forms. Please see notes below, where applicable.
  • BCH-GENE-SCBD-100344-2 Rabies Glycoprotein | Rabies lyssavirus (Rabies virus)
    Protein coding sequence | Resistance to diseases and pests (Viruses)
EN
LMO characteristics
EN
  • Vaccine
Detection method(s)
Pcr
EN
Additional Information
EN